NBTX (Nanobiotix S.A. American Depositary Shares) Stock Analysis - SEC Filings

Nanobiotix S.A. American Depositary Shares (NBTX) is a publicly traded Healthcare sector company. As of May 21, 2026, NBTX trades at $40.16 with a market cap of $2.40B and a P/E ratio of 0.00. NBTX moved -7.86% today. Year to date, NBTX is +106.61%; over the trailing twelve months it is +1018.13%. Its 52-week range spans $2.76 to $57.14. Analyst consensus is strong buy with an average price target of $34.33. Rallies surfaces NBTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find NBTX SEC filings?

Rallies organizes NBTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

NBTX Key Metrics

Key financial metrics for NBTX
MetricValue
Price$40.16
Market Cap$2.40B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$57.14
52-Week Low$2.76
Volume2.00K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest NBTX News

NBTX Analyst Consensus

4 analysts cover NBTX: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.33.

Common questions about NBTX

Where can I find NBTX SEC filings?
Rallies organizes NBTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show NBTX 10-K and 10-Q filings?
Rallies organizes NBTX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is NBTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NBTX. It does not provide personalized investment advice.
NBTX

NBTX